Drug Type Fusion protein |
Synonyms HCW9213 |
Target |
Mechanism CD28 modulators(T-cell-specific surface glycoprotein CD28 modulators), CD3 modulators(T cell surface glycoprotein CD3 modulators), IL15R agonists(Interleukin-15 receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | - | |
Neoplasms | Preclinical | US | - |